BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7691415)

  • 1. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
    Zabner J; Couture LA; Gregory RJ; Graham SM; Smith AE; Welsh MJ
    Cell; 1993 Oct; 75(2):207-16. PubMed ID: 7691415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR; Paradiso AM; Boucher RC
    Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
    Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
    N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells.
    Johnson LG; Boyles SE; Wilson J; Boucher RC
    J Clin Invest; 1995 Mar; 95(3):1377-82. PubMed ID: 7533790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
    Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro.
    Zabner J; Couture LA; Smith AE; Welsh MJ
    Hum Gene Ther; 1994 May; 5(5):585-93. PubMed ID: 7519884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
    Hay JG; McElvaney NG; Herena J; Crystal RG
    Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.
    Zabner J; Cheng SH; Meeker D; Launspach J; Balfour R; Perricone MA; Morris JE; Marshall J; Fasbender A; Smith AE; Welsh MJ
    J Clin Invest; 1997 Sep; 100(6):1529-37. PubMed ID: 9294121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method.
    Zabner J; Wadsworth SC; Smith AE; Welsh MJ
    Gene Ther; 1996 May; 3(5):458-65. PubMed ID: 9156806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice.
    Jiang C; Akita GY; Colledge WH; Ratcliff RA; Evans MJ; Hehir KM; St George JA; Wadsworth SC; Cheng SH
    Hum Gene Ther; 1997 Apr; 8(6):671-80. PubMed ID: 9113507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral gene transfer corrects the ion transport defect in the sinus epithelia of a porcine CF model.
    Potash AE; Wallen TJ; Karp PH; Ernst S; Moninger TO; Gansemer ND; Stoltz DA; Zabner J; Chang EH
    Mol Ther; 2013 May; 21(5):947-53. PubMed ID: 23511247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans.
    Grubb BR; Pickles RJ; Ye H; Yankaskas JR; Vick RN; Engelhardt JF; Wilson JM; Johnson LG; Boucher RC
    Nature; 1994 Oct; 371(6500):802-6. PubMed ID: 7523956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis.
    Knowles MR; Noone PG; Hohneker K; Johnson LG; Boucher RC; Efthimiou J; Crawford C; Brown R; Schwartzbach C; Pearlman R
    Hum Gene Ther; 1998 Jan; 9(2):249-69. PubMed ID: 9472784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis.
    Clarke LL; Grubb BR; Gabriel SE; Smithies O; Koller BH; Boucher RC
    Science; 1992 Aug; 257(5073):1125-8. PubMed ID: 1380724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.